Hexo Corp
TSX:HEXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (0.6), the stock would be worth CA$0.88 (0% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.6 | CA$0.88 |
0%
|
| 3-Year Average | 0.6 | CA$0.88 |
+0%
|
| 5-Year Average | 0.6 | CA$0.88 |
+0%
|
| Industry Average | 1 | CA$1.54 |
+75%
|
| Country Average | 1.7 | CA$2.6 |
+195%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Hexo Corp
TSX:HEXO
|
38.7m CAD | 0.6 | -0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883B USD | 9.2 | 42.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.5B USD | 3.5 | 26.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 2.9 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.3B GBP | 3.7 | 28 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
270.2B USD | 2.6 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF | 2.9 | 20.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 56 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 2.6 | 11.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.8B USD | 1.1 | 19.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2 | 17.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1 |
| Median | 1.7 |
| 70th Percentile | 3.7 |
| Max | 95 179.6 |
Other Multiples
Hexo Corp
Glance View
HEXO Corp. is a consumer packaged goods cannabis company, which creates and distributes products to serve the global cannabis market. The company is headquartered in Gatineau, Quebec and currently employs 1,277 full-time employees. The company went IPO on 2014-11-17. The firm is engaged in cultivating, processing, packaging and distributing cannabis products. The firm serves Canadian adult-use market through its HEXO, HEXO Plus, Up, Bake Sale, Namaste, REUP and Original Stash brands, and the medical market through its HEXO brand. Its HEXO Plus brand offers tetrahydrocannabinol (THC) cannabis and terpene products. Its HEXO brand offers dried flowers, vape carts and vape pens. Its Original Stash brands offers Pre-roll joints, applicator pen, hash, flowers and reserve. Its Up brand offers cold creek Kush, northern berry and ghost train haze.
